Beth Waitzfelder1, Christine Stewart2, Karen J Coleman3, Rebecca Rossom4, Brian K Ahmedani5, Arne Beck6, John E Zeber7, Yihe G Daida8, Connie Trinacty8, Samuel Hubley6, Gregory E Simon2. 1. Kaiser Permanente Center for Health Research - Hawaii, Honolulu, HI, USA. Beth.E.Waitzfelder@kp.org. 2. Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA. 3. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. 4. HealthPartners Institute, Minneapolis, MN, USA. 5. Center for Health Policy & Health Services Research, Behavioral Health Services, Henry Ford Health System, Detroit, MI, USA. 6. Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA. 7. Baylor Scott & White Health, Center for Applied Health Research, Temple, TX, USA. 8. Kaiser Permanente Center for Health Research - Hawaii, Honolulu, HI, USA.
Abstract
BACKGROUND: Depression is prevalent and costly, but despite effective treatments, is often untreated. Recent efforts to improve depression care have focused on primary care settings. Disparities in treatment initiation for depression have been reported, with fewer minority and older individuals starting treatment. OBJECTIVE: To describe patient characteristics associated with depression treatment initiation and treatment choice (antidepressant medications or psychotherapy) among patients newly diagnosed with depression in primary care settings. DESIGN: A retrospective observational design was used to analyze electronic health record data. PATIENTS: A total of 241,251 adults newly diagnosed with depression in primary care settings among five health care systems from 2010 to 2013. MAIN MEASURES: ICD-9 codes for depression, following a 365-day period with no depression diagnosis or treatment, were used to identify new depression episodes. Treatment initiation was defined as a completed psychotherapy visit or a filled prescription for antidepressant medication within 90 days of diagnosis. Depression severity was measured with Patient Health Questionnaire (PHQ-9) scores on the day of diagnosis. KEY RESULTS: Overall, 35.7% of patients with newly diagnosed depression initiated treatment. The odds of treatment initiation among Asians, non-Hispanic blacks, and Hispanics were at least 30% lower than among non-Hispanic whites, controlling for all other variables. The odds of patients aged ≥ 60 years starting treatment were half those of patients age 44 years and under. Treatment initiation increased with depression severity, but was only 53% among patients with a PHQ-9 score of ≥ 10. Among minority patients, psychotherapy was initiated significantly more often than medication. CONCLUSIONS: Screening for depression in primary care is a positive step towards improving detection, treatment, and outcomes for depression. However, study results indicate that treatment initiation remains suboptimal, and disparities persist. A better understanding of patient factors, and particularly system-level factors, that influence treatment initiation is needed to inform efforts by heath care systems to improve depression treatment engagement and to reduce disparities.
BACKGROUND:Depression is prevalent and costly, but despite effective treatments, is often untreated. Recent efforts to improve depression care have focused on primary care settings. Disparities in treatment initiation for depression have been reported, with fewer minority and older individuals starting treatment. OBJECTIVE: To describe patient characteristics associated with depression treatment initiation and treatment choice (antidepressant medications or psychotherapy) among patients newly diagnosed with depression in primary care settings. DESIGN: A retrospective observational design was used to analyze electronic health record data. PATIENTS: A total of 241,251 adults newly diagnosed with depression in primary care settings among five health care systems from 2010 to 2013. MAIN MEASURES: ICD-9 codes for depression, following a 365-day period with no depression diagnosis or treatment, were used to identify new depression episodes. Treatment initiation was defined as a completed psychotherapy visit or a filled prescription for antidepressant medication within 90 days of diagnosis. Depression severity was measured with Patient Health Questionnaire (PHQ-9) scores on the day of diagnosis. KEY RESULTS: Overall, 35.7% of patients with newly diagnosed depression initiated treatment. The odds of treatment initiation among Asians, non-Hispanic blacks, and Hispanics were at least 30% lower than among non-Hispanic whites, controlling for all other variables. The odds of patients aged ≥ 60 years starting treatment were half those of patients age 44 years and under. Treatment initiation increased with depression severity, but was only 53% among patients with a PHQ-9 score of ≥ 10. Among minority patients, psychotherapy was initiated significantly more often than medication. CONCLUSIONS: Screening for depression in primary care is a positive step towards improving detection, treatment, and outcomes for depression. However, study results indicate that treatment initiation remains suboptimal, and disparities persist. A better understanding of patient factors, and particularly system-level factors, that influence treatment initiation is needed to inform efforts by heath care systems to improve depression treatment engagement and to reduce disparities.
Entities:
Keywords:
depression; disparities; primary care; race and ethnicity
Authors: B D Lebowitz; J L Pearson; L S Schneider; C F Reynolds; G S Alexopoulos; M L Bruce; Y Conwell; I R Katz; B S Meyers; M F Morrison; J Mossey; G Niederehe; P Parmelee Journal: JAMA Date: 1997-10-08 Impact factor: 56.272
Authors: Paul A Nutting; Kathryn Rost; Miriam Dickinson; James J Werner; Perry Dickinson; Jeffrey L Smith; Beth Gallovic Journal: J Gen Intern Med Date: 2002-02 Impact factor: 5.128
Authors: Jeff C Huffman; Carol A Mastromauro; Scott R Beach; Christopher M Celano; Christina M DuBois; Brian C Healy; Laura Suarez; Bruce L Rollman; James L Januzzi Journal: JAMA Intern Med Date: 2014-06 Impact factor: 21.873
Authors: Gregory E Simon; Michael Von Korff; Evette J Ludman; Wayne J Katon; Carolyn Rutter; Jürgen Unützer; Elizabeth H B Lin; Terry Bush; Edward Walker Journal: Med Care Date: 2002-10 Impact factor: 2.983
Authors: Gregory M Garrison; Kurt B Angstman; Stephen S O'Connor; Mark D Williams; Timothy W Lineberry Journal: J Am Board Fam Med Date: 2016 Jan-Feb Impact factor: 2.657
Authors: Devon K Check; Marilyn L Kwan; Neetu Chawla; Stacie B Dusetzina; Emily Valice; Isaac J Ergas; Janise M Roh; Tatjana Kolevska; Donald L Rosenstein; Lawrence H Kushi Journal: J Pain Symptom Manage Date: 2018-12-01 Impact factor: 3.612
Authors: Kimberly A Siniscalchi; Marion E Broome; Jason Fish; Joseph Ventimiglia; Julie Thompson; Pratibha Roy; Ronny Pipes; Madhukar Trivedi Journal: J Prim Care Community Health Date: 2020 Jan-Dec
Authors: Mackenzie Hosie Quinn; Matthew Olonoff; Anna-Marika Bauer; Erica Fox; Nancy Jao; Su Fen Lubitz; Frank Leone; Jacqueline K Gollan; Robert Schnoll; Brian Hitsman Journal: Nicotine Tob Res Date: 2022-01-01 Impact factor: 5.825